No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ADPT Adaptive Biotechnologies
- 2.335
- -0.105-4.30%
Close Apr 18 16:00 ET
- 2.340
- +0.005+0.21%
Post 17:03 ET
338.79MMarket Cap-1496P/E (TTM)
2.458High2.330Low2.78MVolume2.450Open2.440Pre Close6.57MTurnover2.87%Turnover RatioLossP/E (Static)145.09MShares9.08052wk High1.10P/B226.08MFloat Cap2.33052wk Low--Dividend TTM96.82MShs Float71.250Historical High--Div YieldTTM5.26%Amplitude2.330Historical Low2.362Avg Price1Lot Size
Post-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Adaptive Biotechnologies to Report First Quarter 2024 Financial Results on May 7, 2024
SEATTLE, April 17, 2024 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (NASDAQ:ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical
Why Travelers Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of The Travelers Companies, Inc. (NYSE:TRV) fell sharply during Wednesday's session following first-quarter earnings. Travelers reported a mixed first quarter, with earnings lagging analyst' e
Adaptive Biotechnologies Names Kyle Piskel New CFO
BTIG Sticks to Their Buy Rating for Adaptive Biotechnologies (ADPT)
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Stock's 33% Dive Might Signal An Opportunity But It Requires Some Scrutiny
To the annoyance of some shareholders, Adaptive Biotechnologies Corporation (NASDAQ:ADPT) shares are down a considerable 33% in the last month, which continues a horrid run for the company.
Express News | BTIG Maintains Buy on Adaptive Biotechnologies, Lowers Price Target to $5
Comments
Recent insider selling at Adaptive Biotechnologies and lack of insider buying in the past year may deter potential investors, despite insiders owning significant shares.
Have Adaptive Biotechnologies Insiders Been Selling Stock?
$Adaptive Biotechnologies(ADPT.US$ Adaptive Biotechnologies Announces New Translational Collaboration to Measure Minimal Residual Disease with clonoSEQ® Assay Across BeiGene's Lymphoid Malignancy Pipeline
3
Recent months saw no insider buying and some selling, potentially raising investor concerns. Lack of recent insider buying combined with sales might demand investor caution.
QUICK SCALP 10 $ADPT — STOCK & OPTION PLAY
ALERT ON: $10.02
ON THE WATCH: $10.10
🥇 SIGNED OF MORE UPTREND: $10.25
NEED IT TO BREAK OVER: $10.36
key indicator for MORE uptrend: $10.42
confirmation uptrend - $10.63
mini breakout - $10.71. $Adaptive Biotechnologies(ADPT.US$
ALERT ON: $10.02
ON THE WATCH: $10.10
🥇 SIGNED OF MORE UPTREND: $10.25
NEED IT TO BREAK OVER: $10.36
key indicator for MORE uptrend: $10.42
confirmation uptrend - $10.63
mini breakout - $10.71. $Adaptive Biotechnologies(ADPT.US$
1
ColumnsTop upgrades and downgrades on 6/3
Upgrades
• $Ciena(CIEN.US$: B.Riley Upgrades to Buy from Neutral - PT $67 (from $65)
• $Ecolab(ECL.US$: Credit Suisse Upgrades to Outperform from Neutral - PT $195 (from $180)
• $Hersha Hospitality Trust(HT.US$: Jefferies Upgrades to Buy from Neutral - PT $13 (from $11)
• $Martin Marietta Materials(MLM.US$: JPMorgan Upgrades to Overweight from Neutral - PT $410 (from $420)
• $Portland General Electric(POR.US$: Goldman Sachs Upgrades to Buy from Neutral - P...
• $Ciena(CIEN.US$: B.Riley Upgrades to Buy from Neutral - PT $67 (from $65)
• $Ecolab(ECL.US$: Credit Suisse Upgrades to Outperform from Neutral - PT $195 (from $180)
• $Hersha Hospitality Trust(HT.US$: Jefferies Upgrades to Buy from Neutral - PT $13 (from $11)
• $Martin Marietta Materials(MLM.US$: JPMorgan Upgrades to Overweight from Neutral - PT $410 (from $420)
• $Portland General Electric(POR.US$: Goldman Sachs Upgrades to Buy from Neutral - P...
16
2
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg